Compare · DFTX vs UPXI
DFTX vs UPXI
Side-by-side comparison of Definium Therapeutics Inc. (DFTX) and Upexi Inc. (UPXI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DFTX and UPXI operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- DFTX is the larger of the two at $2.51B, about 37.6x UPXI ($66.8M).
- Over the past year, DFTX is up 196.5% and UPXI is down 91.8% - DFTX leads by 288.3 points.
- DFTX has hit the wire 3 times in the past 4 weeks while UPXI has been quiet.
- DFTX has more recent analyst coverage (4 ratings vs 2 for UPXI).
PerformanceDFTX+196.46%UPXI-91.83%
2025-06-09+0.00%2026-06-08
- Company
- Definium Therapeutics Inc.
- Upexi Inc.
- Price
- $23.02-2.29%
- $0.98+3.33%
- Market cap
- $2.51B
- $66.8M
- 1M return
- -0.95%
- -27.77%
- 1Y return
- +196.46%
- -91.83%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 3
- 0
- Recent ratings
- 4
- 2
Latest DFTX
- Definium Therapeutics Announces New Employee Inducement Grants
- Definium Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
- Definium Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Definium Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Definium Therapeutics Announces First Patient Dosed in Ascend, the Second Phase 3 Pivotal Study of DT120 ODT in Major Depressive Disorder
- Definium Therapeutics Announces New Employee Inducement Grants
- SEC Form 10-Q filed by Definium Therapeutics Inc.
- Definium Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Definium Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights
- Definium Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026
Latest UPXI
- Amendment: SEC Form SCHEDULE 13G/A filed by Upexi Inc.
- Upexi Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form 10-Q filed by Upexi Inc.
- Upexi Reports Fiscal Third Quarter 2026 Financial Results
- Upexi Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Upexi to Present at the LD Micro Invitational XVI Conference on May 17-19
- Upexi Provides Periodic Update to its Share Repurchase Program
- Upexi to Host Third Quarter 2026 Earnings Call on May 12th at 5:30 p.m. ET
- SEC Form DEF 14A filed by Upexi Inc.
- Upexi Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits